Description
| Product Detail | Information |
|---|---|
| Brand Name | Polmafort |
| Composition | Polmacoxib 2 mg |
| Dosage Form | Capsule |
| Packing | 10×10 Alu |
| Category | Ortho Medicine PCD Range |
| Prescription | Prescription only (Rx) |
| Available For | PCD Pharma Franchise and Distributorship |
Polmafort is a 2 mg capsule of polmacoxib, one of the newest painkillers to reach the Indian market for osteoarthritis. India’s drug regulator approved polmacoxib 2 mg in February 2023 for primary osteoarthritis of the hip and knee. Before that, it had been in use in South Korea since 2015.
Fortune Labs offers Polmacoxib Capsules for PCD pharma distributorship across India. For anyone building an ortho range, this is worth a close look. Most ortho bags are full of aceclofenac, diclofenac, and etoricoxib, molecules that have been around for years and are sold by hundreds of companies. A newer molecule gives your MR something different to talk about when he walks into an orthopaedic surgeon’s chamber.
How Polmacoxib Works
Polmacoxib belongs to the NSAID family, but it is selective. It mainly blocks COX-2, the enzyme that drives pain and swelling in an inflamed joint, while leaving COX-1, which protects the stomach lining, largely alone. That is the same idea behind celecoxib and etoricoxib.
What makes polmacoxib unusual is a second target. It also binds to an enzyme called carbonic anhydrase, which is found in large amounts in red blood cells. Researchers describe this as a tissue-specific approach. The drug is held in the blood cells and works more in inflamed joint tissue, with the aim of reducing exposure elsewhere in the body. How much this matters for long-term heart safety is still being studied, so it is best described as a promising design rather than a proven advantage.
Uses of Polmacoxib Capsules
In India, polmacoxib 2 mg is approved for idiopathic, or primary, osteoarthritis of the hip and knee. This is the wear and tear kind of arthritis that becomes common after middle age, where the cartilage in the joint slowly thins out and leads to pain, stiffness and difficulty walking or climbing stairs.
Doctors use it to manage the pain and inflammation that come with this condition. It does not repair cartilage or reverse arthritis, and it is meant to be used as part of a treatment plan the doctor sets, which often includes exercise, weight control, and physiotherapy.
Why Polmacoxib Has Good Demand Potential
Osteoarthritis of the knee is something almost every orthopaedic clinic in India sees daily, and the number of older people is growing year after year. These patients need pain relief for months, sometimes years, which is exactly what keeps an ortho product moving.
The bigger point for a franchise partner is timing. Polmacoxib is still a fairly new molecule in India. In the trial that supported its approval, the 2 mg dose worked about as well as celecoxib 200 mg for osteoarthritis pain. Doctors who look for options with less stomach trouble than older painkillers are open to trying it, and there are far fewer brands on the market than for long-established NSAIDs. If you introduce it early in your area, you get to build the brand before the market gets crowded.
What You Get as a Polmafort Franchise Partner
You get monopoly rights for your area, so no other Fortune Labs partner sells Polmafort in your territory. In ortho, where a few busy surgeons can drive most of the prescriptions in a district, that protection really counts.
Fortune Labs supports partners with promotional material such as visual aids and product literature, which is important for a new molecule because doctors will want to understand it before they prescribe it. The products come in 10×10 alu packing, are made at WHO-GMP certified units, and are dispatched from Panchkula, Haryana.
Who Can Take This Franchise
Polmafort suits pharma distributors who already work with orthopaedic surgeons, and medical representatives who want to start their own business with a focused ortho range. Existing PCD partners who sell pain and joint products can add it easily, since it goes to the same doctors. You will need a valid drug licence and GST registration.
How to Start Your Ortho PCD Franchise With Fortune Labs
- Send a WhatsApp message, or fill in the inquiry form on this page.
- Share your area so the team can check monopoly availability.
- Choose Polmafort along with other ortho products that suit the doctors you visit.
- Submit your drug license and GST details to complete the paperwork.
- Place your first order and receive the stock with promotional material.
Precautions and Warnings
- Polmacoxib is a prescription medicine and should be used only under a doctor’s advice.
- People with a history of heart disease, stroke, or uncontrolled blood pressure should tell their doctor before using it, as painkillers of this group can affect the heart and blood vessels.
- Anyone with a stomach ulcer, past stomach bleeding, or kidney or liver disease needs a doctor’s assessment first.
- People who are allergic to other painkillers or to sulfa medicines should inform their doctor.
- It is not meant for use during pregnancy or breastfeeding without medical advice, and it is approved for adults with osteoarthritis, not for children.
Possible Side Effects
Polmacoxib is usually well tolerated in studies. Some people may still notice stomach discomfort, indigestion, or nausea. As with other painkillers of this group, a few may get swelling in the feet or a rise in blood pressure. Anyone who has chest pain, breathlessness, black stools, or a skin rash while taking it should contact their doctor straight away.
Frequently Asked Questions
Q1. What is Polmacoxib capsule used for?
Ans: It is used to manage pain and inflammation in primary osteoarthritis of the hip and knee. This is the approved use for polmacoxib 2 mg in India.
Q2. Is polmacoxib approved in India?
Ans: Yes. India’s drug regulator approved polmacoxib 2 mg capsules in February 2023 for primary osteoarthritis of the hip and knee. The molecule was first approved in South Korea in 2015.
Q3. How is polmacoxib different from other painkillers?
Ans: It mainly blocks COX-2, like celecoxib and etoricoxib, which is linked to fewer stomach problems than older painkillers. It also binds to carbonic anhydrase, which is meant to keep its action focused on inflamed joint tissue.
Q4. Is Polmafort available for PCD franchise?
Ans: Yes. Fortune Labs offers Polmafort for PCD pharma distributorship across India, with monopoly rights in your area, subject to availability.
Q5. What is the packing of Polmafort?
Ans: Polmafort comes in a 10×10 alu pack.
Q6. Which doctors prescribe polmacoxib?
Ans: Orthopaedic surgeons are the main prescribers. Physicians and rheumatologists who treat osteoarthritis patients may also prescribe it.
Q7. Can I add other ortho products along with Polmafort?
Ans: Yes. Fortune Labs has other pain and ortho products such as aceclofenac, diclofenac and nimesulide combinations, so you can build a full ortho range around Polmafort.
Grow Your Ortho Range With Polmafort
Every ortho franchise sells painkillers, and that is exactly the problem. When every company offers the same aceclofenac and diclofenac combinations, the conversation with the doctor becomes all about price. A newer molecule like polmacoxib changes that conversation.
Polmafort gives you an approved osteoarthritis molecule, a clear story about how it works, and monopoly rights in your territory. Introduce it to the orthopaedic surgeons you already visit, and let your older pain products support it.
To check whether your area is available for Polmafort, call now.
